Welcome to our dedicated page for Arcbest SEC filings (Ticker: ARCB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ArcBest鈥檚 supply chain world is fast-moving鈥攆uel prices swing, freight volumes shift, and ABF Freight鈥檚 union contract can influence margins almost overnight. That complexity runs straight into the hundreds of pages in every 10-K and 10-Q. If you have ever asked, 鈥淲here can I find ArcBest鈥檚 quarterly earnings report 10-Q filing?鈥� or 鈥淗ow do ArcBest insider trading Form 4 transactions signal management confidence?鈥� this page is built for you.
Stock Titan鈥檚 AI scans each submission to EDGAR the moment it posts, then distills the essentials: segment operating ratio, equipment capital plans, pension liabilities, even how many tractors ArcBest retired this quarter. Our AI-powered summaries turn arcane accounting notes into plain language so you can understand ArcBest SEC filings explained simply鈥攚ithout sifting through footnotes.
Explore every document type in one place:
- 10-K annual report 10-K simplified鈥攕ee how asset-based vs. asset-light revenue mix changed.
- Form 4 insider transactions real-time鈥攖rack executive stock transactions before freight rate announcements.
- 8-K material events explained鈥攄ig into sudden labor updates or fleet acquisitions.
- Proxy statement executive compensation鈥攃ompare pay to ArcBest鈥檚 return on invested capital.
Because filings arrive continuously, real-time alerts ensure you never miss an ArcBest earnings report filing analysis or a new ArcBest Form 4 insider transactions update. Professionals monitor freight demand cycles; analysts track cash used for tractor upgrades; activists watch pension obligations. Whatever your angle, our expert analysis and AI summaries make it quicker to act on ArcBest disclosures.
N2OFF, Inc. (Nasdaq: NITO) has called a 2025 special meeting to seek shareholder approval for four key proposals.
- Acquisition: N2OFF will buy 100% of Israeli oncology start-up MitoCareX Bio Ltd. by issuing new NITO shares equal to 鈮�40% of post-close fully diluted shares plus up to another 25% in milestone stock, $700k cash and up to $1.6 m of future-financing proceeds. MitoCareX founders will also receive 5% RSUs and board control of the subsidiary.
- Reverse split: Board authority to effect a 1-for-2 to 1-for-150 reverse split within 12 months.
- Warrants: Approval to issue 1,850,000 common shares on exercise of a warrant held by L.I.A. Pure Capital Ltd.
- Adjournment: Standard authority if more time is needed to solicit votes.
The board unanimously recommends voting FOR all items. If approved, existing holders face substantial dilution, potential additional issuance through milestones and warrants, and the possibility of a large reverse split to maintain Nasdaq compliance. The deal adds an early-stage oncology platform but exposes N2OFF to R&D funding obligations and integration risks. Two N2OFF directors also serve on MitoCareX seller SciSparc鈥檚 board, creating related-party considerations.
Moog Inc. (MOG.A / MOG.B) filed a Form 8-K dated 25 Jul 2025. Under Item 2.02, the company furnished Exhibit 99.1, a press release discussing results for the quarter ended 28 Jun 2025; however, the filing itself does not reproduce revenue, EPS, backlog or guidance figures, so investors must review the exhibit for specifics.
Under Item 8.01, the Board declared a $0.29 per-share cash dividend on both Class A and Class B common stock. The dividend is payable 26 Aug 2025 to shareholders of record as of 8 Aug 2025. No other material events, financings or strategic actions were disclosed. Exhibits 99.1 (earnings press release) and 99.2 (dividend press release) accompany the report.
Intel (INTC) filed an 8-K covering two material items.
Item 2.02 鈥� Results: A furnished press release (Ex. 99.1) contains full Q2-25 GAAP and non-GAAP figures and Q3 outlook; those numbers are not repeated in this filing.
Item 2.05 鈥� 2025 Restructuring Plan: Approved 10-Jul-25 and announced 24-Jul-25, the programme will cut the core workforce by 15 % by FY-25, streamline layers and redirect spending to client & server lines while exiting lower-priority businesses.
Financial impact: Intel expects $1.9 bn total charges; $1.8 bn will be booked in Q2-25. Components are $1.4 bn cash severance and $416 m non-cash asset impairments tied to business exits and real-estate consolidation. Actions should be 鈥渟ubstantially complete鈥� by Q4-25.
Forward-looking language cautions that timing, costs and savings may change.
Near-term GAAP earnings will absorb large charges, but management signals longer-term margin expansion and tighter strategic focus.
FAQ
What is the current stock price of Arcbest (ARCB)?
What is the market cap of Arcbest (ARCB)?
What are the primary operating segments of ArcBest Corp?
How does ArcBest differentiate between its asset-based and asset-light services?
What types of logistics solutions does ArcBest offer?
How does technology play a role in ArcBest's operations?
Who are the typical clients of ArcBest Corp?
What benefits do customers gain from ArcBest's integrated logistics model?
How does ArcBest maintain its market position in the competitive logistics industry?
What are the key industry challenges addressed by ArcBest?
